Li G - Search Results

1

An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers.

Ball G, Mian S, Holding F, Allibone RO, Lowe J, Ali S, Li G, McCardle S, Ellis IO, Creaser C, Rees RC. Ball G, et al. Among authors: li g. Bioinformatics. 2002 Mar;18(3):395-404. doi: 10.1093/bioinformatics/18.3.395. Bioinformatics. 2002. PMID: 11934738

2

A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditions.

Mian S, Ball G, Hornbuckle J, Holding F, Carmichael J, Ellis I, Ali S, Li G, McArdle S, Creaser C, Rees R. Mian S, et al. Among authors: li g. Proteomics. 2003 Sep;3(9):1725-37. doi: 10.1002/pmic.200300526. Proteomics. 2003. PMID: 12973733

3

Immunity to tumour antigens.

Li G, Ali SA, McArdle SE, Mian S, Ahmad M, Miles A, Rees RC. Li G, et al. Curr Pharm Des. 2005;11(27):3501-9. doi: 10.2174/138161205774414583. Curr Pharm Des. 2005. PMID: 16248804 Review.

4

Phenotypic and functional differences of dendritic cells generated under different in vitro conditions.

McArdle SE, Ali SA, Li G, Mian S, Rees RC. McArdle SE, et al. Among authors: li g. Methods Mol Med. 2003;81:359-75. doi: 10.1385/1-59259-372-0:359. Methods Mol Med. 2003. PMID: 12725131 No abstract available.

5

Progress in vaccination against cancer (PIVAC) 2002.

Li G, Rees RC. Li G, et al. Expert Rev Vaccines. 2002 Oct;1(3):261-3. doi: 10.1586/14760584.1.3.261. Expert Rev Vaccines. 2002. PMID: 12901566 Free article. No abstract available.

6

The identification of human tumour antigens: Current status and future developments.

Miles AK, Matharoo-Ball B, Li G, Ahmad M, Rees RC. Miles AK, et al. Among authors: li g. Cancer Immunol Immunother. 2006 Aug;55(8):996-1003. doi: 10.1007/s00262-005-0115-5. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408215 Free PMC article. Review.

7

Identification of tumour antigens by serological analysis of cDNA expression cloning.

Li G, Miles A, Line A, Rees RC. Li G, et al. Cancer Immunol Immunother. 2004 Mar;53(3):139-43. doi: 10.1007/s00262-003-0471-y. Epub 2004 Jan 13. Cancer Immunol Immunother. 2004. PMID: 14722670 Free PMC article. Review.

8

Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.

Rees RC, McArdle S, Mian S, Li G, Ahmad M, Parkinson R, Ali SA. Rees RC, et al. Among authors: li g. Curr Opin Mol Ther. 2002 Feb;4(1):49-53. Curr Opin Mol Ther. 2002. PMID: 11883695 Review.

9

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.

Parkinson RJ, Mian S, Bishop MC, Gray T, Li G, McArdle SE, Ali S, Rees RC. Parkinson RJ, et al. Among authors: li g. Prostate. 2003 Jun 15;56(1):65-73. doi: 10.1002/pros.10207. Prostate. 2003. PMID: 12746848

10

Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53.

Rojas JM, McArdle SE, Horton RB, Bell M, Mian S, Li G, Ali SA, Rees RC. Rojas JM, et al. Among authors: li g. Cancer Immunol Immunother. 2005 Mar;54(3):243-53. doi: 10.1007/s00262-004-0596-7. Epub 2004 Sep 21. Cancer Immunol Immunother. 2005. PMID: 15449037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,733 results

Search Page

Filters